• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B型利钠肽水平在左心室射血分数较高的心力衰竭患者中的预后价值

Prognostic Value of B-Type Natriuretic Peptide Level in Patients With Heart Failure With a Higher Left Ventricular Ejection Fraction.

作者信息

Ohte Nobuyuki, Kikuchi Shohei, Iwahashi Noriaki, Kinugasa Yoshiharu, Dohi Kaoru, Takase Hiroyuki, Inoue Katsuji, Okumura Takahiro, Hachiya Kenta, Sugiura Emiyo, Kusunose Kenya, Kitada Shuichi, Seo Yoshihiro

机构信息

Department of Cardiology, Nagoya City University Graduate School of Medical Sciences Nagoya Japan.

Department of Cardiology, Yokohama City University School of Medicine Yokohama Japan.

出版信息

Circ Rep. 2025 Feb 8;7(3):191-197. doi: 10.1253/circrep.CR-24-0172. eCollection 2025 Mar 10.

DOI:10.1253/circrep.CR-24-0172
PMID:40066216
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11890284/
Abstract

BACKGROUND

In heart failure (HF) patients with a higher left ventricular ejection fraction (LVEF), the B-type natriuretic peptide (BNP) level is yet to be fully assessed. Accordingly, we hypothesized that the BNP level should be higher in patients with a higher LVEF range based on the previous finding that such patients were associated with a worse prognosis.

METHODS AND RESULTS

In our multicenter, prospective, observational cohort for the composite endpoint of all-cause death and readmission due to HF, including patients with LVEF >40% at hospital discharge, we obtained LVEF, E/e', and BNP levels in 231 patients. The concurrent atrial fibrillation (AF) was confirmed by electrocardiogram. Patients were divided into HF with mildly reduced EF (HFmrEF), HF with preserved EF (HFpEF) with LVEF ≥50 and <60%, and HFpEF with LVEF ≥60%. The BNP levels were not significantly different among these groups (median [interquartile range]: 195 [110-348] vs. 242 [150-447] vs. 220 [125-320] pg/mL, respectively; P=0.422). In contrast, a BNP level of ≥377 pg/mL could significantly differentiate event-free survival (P<0.001). In the multi-covariate Cox proportional hazards model, the BNP level was significantly related to event-free survival independent of LVEF, E/e', and concurrent AF.

CONCLUSIONS

Without confounding the effects of LVEF, E/e', and concurrent AF, higher BNP levels are significantly and independently associated with event-free survival in HF patients with LVEF>40%.

摘要

背景

在左心室射血分数(LVEF)较高的心力衰竭(HF)患者中,B型利钠肽(BNP)水平尚未得到充分评估。因此,基于之前发现此类患者预后较差这一结果,我们推测LVEF范围较高的患者BNP水平应该更高。

方法和结果

在我们针对全因死亡和因HF再次入院这一复合终点的多中心、前瞻性、观察性队列研究中,纳入了出院时LVEF>40%的患者,我们获取了231例患者的LVEF、E/e'和BNP水平。通过心电图确认并发心房颤动(AF)情况。患者被分为射血分数轻度降低的HF(HFmrEF)、LVEF≥50%且<60%的射血分数保留的HF(HFpEF)以及LVEF≥60%的HFpEF。这些组之间的BNP水平无显著差异(中位数[四分位间距]:分别为195[110 - 348]、242[150 - 447]和220[125 - 320]pg/mL;P = 0.422)。相比之下,BNP水平≥377 pg/mL能够显著区分无事件生存期(P<0.001)。在多变量Cox比例风险模型中,BNP水平与无事件生存期显著相关,且独立于LVEF、E/e'和并发AF。

结论

在不混淆LVEF、E/e'和并发AF影响的情况下,较高的BNP水平与LVEF>40%的HF患者的无事件生存期显著且独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8768/11890284/92ad8a66a606/circrep-7-191-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8768/11890284/ecbb324fa159/circrep-7-191-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8768/11890284/8fe44914cdf8/circrep-7-191-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8768/11890284/92ad8a66a606/circrep-7-191-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8768/11890284/ecbb324fa159/circrep-7-191-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8768/11890284/8fe44914cdf8/circrep-7-191-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8768/11890284/92ad8a66a606/circrep-7-191-g003.jpg

相似文献

1
Prognostic Value of B-Type Natriuretic Peptide Level in Patients With Heart Failure With a Higher Left Ventricular Ejection Fraction.B型利钠肽水平在左心室射血分数较高的心力衰竭患者中的预后价值
Circ Rep. 2025 Feb 8;7(3):191-197. doi: 10.1253/circrep.CR-24-0172. eCollection 2025 Mar 10.
2
Catheter ablation for non-paroxysmal atrial fibrillation accompanied by heart failure with preserved ejection fraction: feasibility and benefits in functions and B-type natriuretic peptide.导管消融治疗射血分数保留的心力衰竭伴非阵发性心房颤动:对功能和 B 型利钠肽的可行性和益处。
Europace. 2021 Aug 6;23(8):1252-1261. doi: 10.1093/europace/euaa420.
3
B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.B 型利钠肽与射血分数保留和降低心力衰竭患者的预后。
J Am Coll Cardiol. 2013 Apr 9;61(14):1498-506. doi: 10.1016/j.jacc.2012.12.044.
4
Unfavourable outcomes in patients with heart failure with higher preserved left ventricular ejection fraction.左心室射血分数保留较高的心力衰竭患者的不良结局。
Eur Heart J Cardiovasc Imaging. 2023 Feb 17;24(3):293-300. doi: 10.1093/ehjci/jeac240.
5
Relationship of ejection fraction and natriuretic peptide trajectories in heart failure with baseline reduced and mid-range ejection fraction.射血分数与心力衰竭中基线射血分数降低和中间范围的利钠肽轨迹的关系。
Am Heart J. 2022 Jan;243:1-10. doi: 10.1016/j.ahj.2021.08.015. Epub 2021 Aug 25.
6
The prognostic value of brain natriuretic peptide in patients with heart failure and left ventricular ejection fraction higher than 60%: a sub-analysis of the J-MELODIC study.脑利钠肽在射血分数高于 60%的心衰患者中的预后价值:J-MELODIC 研究的亚组分析。
ESC Heart Fail. 2018 Feb;5(1):36-45. doi: 10.1002/ehf2.12206. Epub 2017 Sep 21.
7
Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.ST2 与 B 型利钠肽联合检测在糖尿病合并急性心力衰竭患者中的应用:与心室僵硬度和预后的关系。
J Cardiovasc Med (Hagerstown). 2019 Feb;20(2):81-90. doi: 10.2459/JCM.0000000000000741.
8
Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.用多非利特治疗射血分数保留和轻度降低的心衰伴发的心房颤动:ATHENA 试验的事后分析。
Eur J Heart Fail. 2022 Jun;24(6):1094-1101. doi: 10.1002/ejhf.2487. Epub 2022 Apr 10.
9
Predictors and prognostic implications of left ventricular ejection fraction trajectory improvement in the spectrum of heart failure with reduced and mildly reduced ejection fraction.射血分数降低和轻度降低的心力衰竭谱中左心室射血分数轨迹改善的预测因素及其预后意义。
J Cardiol. 2024 Apr;83(4):250-257. doi: 10.1016/j.jjcc.2023.09.012. Epub 2023 Oct 5.
10
Differential Associations of A-/B-Type Natriuretic Peptides With Cardiac Structure, Function, and Prognosis in Heart Failure.A 型和 B 型利钠肽与心力衰竭患者心脏结构、功能和预后的相关性差异。
JACC Heart Fail. 2024 Mar;12(3):461-474. doi: 10.1016/j.jchf.2023.09.011. Epub 2023 Oct 25.

引用本文的文献

1
Rationale and Design of the ESPIAL Trial - A Prospective, Randomized, Exploratory Study to Evaluate the Effect of Esaxerenone on Reduction of Urinary Albumin to Creatinine Ratio in Hypertensive Patients Concomitant With Heart Failure and Albuminuria.依普利酮治疗试验(ESPIAL)的原理与设计——一项前瞻性、随机、探索性研究,旨在评估依普利酮对降低合并心力衰竭和蛋白尿的高血压患者尿白蛋白与肌酐比值的效果。
Circ Rep. 2025 Jul 12;7(9):826-831. doi: 10.1253/circrep.CR-25-0070. eCollection 2025 Sep 10.

本文引用的文献

1
Left Ventricular Diastolic Dysfunction in Patients With Heart Failure With a Higher Left Ventricular Ejection Fraction and Its Relation to Prognosis.
J Am Soc Echocardiogr. 2024 Dec;37(12):1182-1183. doi: 10.1016/j.echo.2024.09.003. Epub 2024 Sep 15.
2
Distinctive left ventricular-arterial and right ventricular-pulmonary arterial coupling observed in patients with heart failure and a higher left ventricular ejection fraction range.在心力衰竭且左心室射血分数范围较高的患者中观察到独特的左心室-动脉和右心室-肺动脉耦合。
Eur Heart J Cardiovasc Imaging. 2024 May 31;25(6):774-781. doi: 10.1093/ehjci/jeae033.
3
Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society.利钠肽:在心力衰竭诊断和管理中的作用:欧洲心脏病学会心力衰竭协会、美国心力衰竭学会和日本心力衰竭学会的科学声明。
J Card Fail. 2023 May;29(5):787-804. doi: 10.1016/j.cardfail.2023.02.009. Epub 2023 Apr 17.
4
Prognostic Implications of Left Ventricular Ejection Fraction and Left Ventricular End-Diastolic Diameter on Clinical Outcomes in Patients with ICD.植入式心脏复律除颤器(ICD)患者左心室射血分数和左心室舒张末期内径对临床结局的预后影响
J Cardiovasc Dev Dis. 2022 Nov 28;9(12):421. doi: 10.3390/jcdd9120421.
5
Unfavourable outcomes in patients with heart failure with higher preserved left ventricular ejection fraction.左心室射血分数保留较高的心力衰竭患者的不良结局。
Eur Heart J Cardiovasc Imaging. 2023 Feb 17;24(3):293-300. doi: 10.1093/ehjci/jeac240.
6
Lower B-type natriuretic peptide levels predict left ventricular concentric remodelling and insulin resistance.较低的 B 型利钠肽水平可预测左心室向心性重构和胰岛素抵抗。
ESC Heart Fail. 2022 Feb;9(1):636-647. doi: 10.1002/ehf2.13700. Epub 2021 Nov 16.
7
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone.射血分数保留的心力衰竭中的临床表型组:详细表型、预后及对螺内酯的反应
JACC Heart Fail. 2020 Mar;8(3):172-184. doi: 10.1016/j.jchf.2019.09.009. Epub 2020 Jan 8.
8
How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).如何诊断射血分数保留的心力衰竭:HFA-PEFF 诊断算法:欧洲心脏病学会(ESC)心力衰竭协会(HFA)的共识推荐。
Eur Heart J. 2019 Oct 21;40(40):3297-3317. doi: 10.1093/eurheartj/ehz641.
9
Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?在临床实践中, routinely reported 射血分数和死亡率:风险最低点在哪里?
Eur Heart J. 2020 Mar 21;41(12):1249-1257. doi: 10.1093/eurheartj/ehz550.
10
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.N端前B型利钠肽水平在伴或不伴心房颤动的心力衰竭患者中的预后价值
Circ Heart Fail. 2017 Oct;10(10). doi: 10.1161/CIRCHEARTFAILURE.117.004409.